Table 1 Correlation of EZH2 expression with clinicopathologic feature in PTC
From: EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma
Clinicopathologic parameters | Case no. | EZH2 expression | P-value | |
|---|---|---|---|---|
Low | High | |||
Total cases | 65 | 27 | 38 | |
Age | 0.4033 | |||
≤ 45 | 40 | 15 | 25 | |
> 45 | 25 | 12 | 13 | |
Gender | 0.3751 | |||
Male | 7 | 4 | 3 | |
Female | 58 | 23 | 35 | |
Tumor size | 0.8904 | |||
≤ 1 cm | 18 | 10 | 8 | |
> 1 cm | 47 | 27 | 20 | |
Extrathryoid extension | 0.1899 | |||
No | 59 | 23 | 36 | |
Yes | 6 | 4 | 2 | |
Lymph node metastasis | 0.0073 | |||
No | 37 | 23 | 14 | |
Yes | 28 | 8 | 20 | |
Recurrent | 0.0302 | |||
No | 59 | 27 | 32 | |
Yes | 6 | 0 | 6 | |